Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Baxter International Inc.
  6. Summary
    BAX   US0718131099

BAXTER INTERNATIONAL INC.

(BAX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/09/2021 06/10/2021 06/11/2021 06/14/2021 06/15/2021 Date
82.35(c) 84.09(c) 82.24(c) 82.77(c) 81.95 Last
1 707 238 3 455 650 6 107 155 2 994 508 2 273 929 Volume
+1.55% +2.11% -2.20% +0.64% -0.99% Change
More quotes
Financials (USD)
Sales 2021 12 657 M - -
Net income 2021 1 636 M - -
Net Debt 2021 2 243 M - -
P/E ratio 2021 27,3x
Yield 2021 1,24%
Sales 2022 13 307 M - -
Net income 2022 1 931 M - -
Net Debt 2022 1 916 M - -
P/E ratio 2022 22,0x
Yield 2022 1,37%
Capitalization 41 621 M 41 621 M -
EV / Sales 2021 3,47x
EV / Sales 2022 3,27x
Nbr of Employees 50 000
Free-Float 73,4%
More Financials
Company
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition... 
Read more
More about the company
Ratings of Baxter International Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about BAXTER INTERNATIONAL INC.
04:17pBAXTER INTERNATIONAL  : to Host Second-Quarter 2021 Financial Results Conference..
BU
06/08BAXTER INTERNATIONAL  : Presents Data at 58th ERA-EDTA Congress Indicating Thera..
BU
06/03BAXTER INTERNATIONAL INC. : Ex-dividend day for
FA
06/02BAXTER INTERNATIONAL  : Launches the Sharesource Analytics 1.0 Digital Health Mo..
BU
05/25BAXTER INTERNATIONAL  : Barclays Starts Baxter International at Equalweight with..
MT
05/25BAXTER INTERNATIONAL  : Launches PrisMax 2 System to Advance Critical Care Deliv..
BU
05/11PRESS RELEASE : MIG portfolio company AMSilk completes EUR29 million financing r..
DJ
05/05BAXTER INTERNATIONAL INC  : Submission of Matters to a Vote of Security Holders ..
AQ
05/04BAXTER INTERNATIONAL  : to Present at the UBS Global Healthcare Virtual Conferen..
BU
05/04BAXTER INTERNATIONAL  : Ups Dividend by 14% to $0.28/Share, Payable on July 1 to..
MT
05/04BAXTER INTERNATIONAL  : Board Boosts Quarterly Dividend By 14%
MT
05/03Baxter International Raises Dividend 14%
DJ
05/03BAXTER INTERNATIONAL  : Increases Dividend and Declares Quarterly Dividend
BU
04/30BAXTER INTERNATIONAL  : UBS Adjusts Baxter International's Price Target to $90 F..
MT
04/30BAXTER INTERNATIONAL  : Citigroup Adjusts Baxter International's Price Target to..
MT
More news
News in other languages on BAXTER INTERNATIONAL INC.
04/27DGAP-NEWS : MIG AG verzeichnet 2020 bestes Jahr der Unternehmensgeschichte und s..
03/15HINTERGRUND/Biontech formt globale Allianz für mehr Corona-Impfstoff
03/08MODERNA  : Baxter International va aider à fabriquer le vaccin
02/23Farmacéuticas rivales se unen para fabricar más vacunas de Covid-19
2020EN DIRECT DES MARCHES  : Sanofi, Dassault, Ubisoft, Softbank, Vale, Tesla, Signi..
More news
Analyst Recommendations on BAXTER INTERNATIONAL INC.
More recommendations
Analysis
One of the few top U.S. Black CEOs, Merck's Ken Frazier to retire
Chart BAXTER INTERNATIONAL INC.
Duration : Period :
Baxter International Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAXTER INTERNATIONAL INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 93,59 $
Last Close Price 82,77 $
Spread / Highest target 26,9%
Spread / Average Target 13,1%
Spread / Lowest Target -3,35%
EPS Revisions
Managers and Directors
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
James K. Saccaro Chief Financial Officer & Executive Vice President
Sumant Ramachandra Senior VP, Chief Science & Technology Officer
Tobi Karchmer Vice President-Worldwide Medical
Talvis Love Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL INC.3.15%41 621
ABBOTT LABORATORIES0.90%196 303
MEDTRONIC PLC5.98%167 031
BECTON, DICKINSON AND COMPANY-3.00%70 587
ALIGN TECHNOLOGY, INC.13.36%47 939
HOYA CORPORATION-1.68%47 159